Patient preferences for whole-body MRI or conventional staging pathways in lung and colorectal cancer: a discrete choice experiment
Tóm tắt
To determine the importance placed by patients on attributes associated with whole-body MRI (WB-MRI) and standard cancer staging pathways and ascertain drivers of preference. Patients recruited to two multi-centre diagnostic accuracy trials comparing WB-MRI with standard staging pathways in lung and colorectal cancer were invited to complete a discrete choice experiment (DCE), choosing between a series of alternate pathways in which 6 attributes (accuracy, time to diagnosis, scan duration, whole-body enclosure, radiation exposure, total scan number) were varied systematically. Data were analysed using a conditional logit regression model and marginal rates of substitution computed. The relative importance of each attribute and probabilities of choosing WB-MRI-based pathways were estimated. A total of 138 patients (mean age 65, 61% male, lung n = 72, colorectal n = 66) participated (May 2015 to September 2016). Lung cancer patients valued time to diagnosis most highly, followed by accuracy, radiation exposure, number of scans, and time in the scanner. Colorectal cancer patients valued accuracy most highly, followed by time to diagnosis, radiation exposure, and number of scans. Patients were willing to wait 0.29 (lung) and 0.45 (colorectal) weeks for a 1% increase in pathway accuracy. Patients preferred WB-MRI-based pathways (probability 0.64 [lung], 0.66 [colorectal]) if they were equivalent in accuracy, total scan number, and time to diagnosis compared with a standard staging pathway. Staging pathways based on first-line WB-MRI are preferred by the majority of patients if they at least match standard pathways for diagnostic accuracy, time to diagnosis, and total scan number.
• WB-MRI staging pathways are preferred to standard pathways by the majority of patients provided they at least match standard staging pathways for accuracy, total scan number, and time to diagnosis.
• For patients with lung cancer, time to diagnosis was the attribute valued most highly, followed by accuracy, radiation dose, number of additional scans, and time in a scanner. Preference for patients with colorectal cancer was similar.
• Most (63%) patients were willing to trade attributes, such as faster diagnosis, for improvements in pathway accuracy and reduced radiation exposure.
Tài liệu tham khảo
Ciliberto M, Maggi F, Treglia G et al (2013) Comparison between whole-body MRI and fluorine-18-fluorodeoxyglucose PET or PET/CT in oncology: a systematic review. Radiol Oncol 47:206–218
Usuda K, Sagawa M, Maeda S et al (2016) Diagnostic performance of whole-body diffusion-weighted imaging compared to PET-CT plus brain MRI in staging clinically resectable lung cancer. Asian Pac J Cancer Prev 17:2775–2780
Evans REC, Taylor S, Janes S et al (2017) Patient experience and perceived acceptability of whole-body magnetic resonance imaging for staging colorectal and lung cancer compared with current staging scans: a qualitative study. BMJ Open 7:e016391
Evans REC, Taylor S, Beare S et al (2018) Perceived patient burden and acceptability of whole body MRI for staging lung and colorectal cancer; comparison with standard staging investigations. Br J Radiol 91:20170731
Dewey M, Schink T, Dewey CF (2007) Claustrophobia during magnetic resonance imaging: cohort study in over 55,000 patients. J Magn Reson Imaging 26:1322–1327
Hummel JM, Steuten LG, Groothuis-Oudshoorn CJ, Mulder N, Ijzerman MJ (2013) Preferences for colorectal cancer screening techniques and intention to attend: a multi-criteria decision analysis. Appl Health Econ Health Policy 11:499–507
Petersen GS, Knudsen JL, Vinter MM (2015) Cancer patients’ preferences of care within hospitals: a systematic literature review. Int J Qual Health Care 27:384–395
Ryan M, Watson W, Gerard K (2008) Practical issues in conducting a discrete choice experiment. In: Ryan M, Gerard K, Amaya-Amaya M (eds) Using discrete choice experiments to value health and healthcare. Springer, Dordrecht, pp 73–97
Lancsar E, Louviere J (2008) Conducting discrete choice experiments to inform healthcare decision making: a user’s guide. Pharmacoeconomics 26:661–677
Bridges JF, Hauber AB, Marshall D et al (2011) Conjoint analysis applications in health--a checklist: a report of the ISPOR good research practices for conjoint analysis task force. Value Health 14:403–413
Taylor SA, Mallett S, Miles A et al (2017) Streamlining staging of lung and colorectal cancer with whole body MRI; study protocols for two multicentre, non-randomised, single-arm, prospective diagnostic accuracy studies (streamline C and streamline L). BMC Cancer 17:299
Ohno Y, Koyama H, Onishi Y et al (2008) Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. Radiology 248:643–654
Ohno Y, Koyama H, Yoshikawa T et al (2015) Three-way comparison of whole-body MR, coregistered whole-body FDG PET/MR, and integrated whole-body FDG PET/CT imaging: TNM and stage assessment capability for non-small cell lung cancer patients. Radiology 275:849–861
Hall EJ, Brenner DJ (2008) Cancer risks from diagnostic radiology. Br J Radiol 81:362–378
Hahn G, Shaprio S (1966) A catalogue and computer program for the design and analysis of orthogonal symmetric and asymmetric fractional factorial experiments. General Electric Research and Development Centre, Schenectady
Vallejo-Torres L, Melnychuk M, Vindrola-Padros C et al (2018) Discrete-choice experiment to analyse preferences for centralizing specialist cancer surgery services. Br J Surg 105:587–596
Watson D, Clark LA, Tellegen A (1988) Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 54:1063–1070
Crawford JR, Henry JD (2004) The positive and negative affect schedule (PANAS): construct validity, measurement properties and normative data in a large non-clinical sample. Br J Clin Psychol 43:245–265
Hauber AB, Gonzalez JM, Groothuis-Oudshoorn CG et al (2016) Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR conjoint analysis good research practices task force. Value Health 19:300–315
Adams HJ, Kwee TC, Vermoolen MA, Ludwig I, Bierings MB, Nievelstein RA (2014) Whole-body MRI vs. CT for staging lymphoma: patient experience. Eur J Radiol 83:163–166
Eshed I, Althoff CE, Hamm B, Hermann KG (2007) Claustrophobia and premature termination of magnetic resonance imaging examinations. J Magn Reson Imaging 26:401–404